Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07676565 · ClinicalTrials.gov registry record
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
A clinical trial, sponsored by Indiana University.
- Recruiting
- Registry status
- 300
- Enrollment target
NCT07676565 is a clinical trial that is actively recruiting participants, run by Indiana University. The registered enrollment target is 300 participants.
The verdict
NCT07676565 is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
Study Summary
This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-03-24 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07676565
The ClinicalTrials.gov registry entry for NCT07676565 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07676565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07676565 about?
NCT07676565 is a clinical study titled "Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study". This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.
What is the current status of trial NCT07676565?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-03-24. Estimated completion is 2028-04.
Who is sponsoring clinical trial NCT07676565?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.